Loading stock data…
Stevanato Group S.p.A. engages in the design (STVN)
$19.68+0.28 (+1.44%)
Market ClosedLast close Jul 24
Stevanato Group S.p.A.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Stevanato Group S.p.A. in the Healthcare sector is trading at $19.68 with a market capitalization of $4.5B. Wall Street consensus targets $24.45 (10 analysts), implying a +24.2% move over the next 12 months. The stock is currently 30% below its 52-week high of $28.00, remaining 4.7% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +24.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $273.57M↓ | $346.48M↑ | $303.17M↑ | $280.00M↑ | $256.60M |
| Gross Profit | $75.18M↓ | $106.90M↑ | $88.50M↑ | $78.60M↑ | $69.89M |
| Operating Income | $38.74M↓ | $70.08M↑ | $52.72M↑ | $41.40M↑ | $34.63M |
| Net Income | $28.03M↓ | $47.55M↑ | $36.06M↑ | $29.70M↑ | $26.52M |
Peer Comparison
JNJUNHPFE
Fundamentals
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. ...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$4.50B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
9.23%
Volume
Today's trading volume
292,487
Recent News
Profound Medical (PROF) Moves 8.2% Higher: Will This Strength Last?
Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
TimesSquare Mid Cap Growth Strategy Downplays Market Fears on Stevanato Group S.p.A. (STVN)
TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. The Strategy fell 7.72% (net) in the quarter compared to -6.35% for the Russell Midcap Growth Index. In the first quarter, markets navigated geopolitical tensions and economic resilience alongside […]
Aurinia (AUPH) Moves 6.5% Higher: Will This Strength Last?
Aurinia (AUPH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Stevanato Group (STVN) Stock Valuation Check After Recent Share Price Weakness
Stevanato Group stock overview after recent performance moves Stevanato Group (STVN) stock has been under pressure recently, with the price down 1.2% over the past day, 7.5% over the past week, and about 5% over the past month. That shorter term weakness sits alongside a gain of roughly 11% over the past 3 months, set against a decline of about 17% year to date and around 27% over the past year for long term holders. See our latest analysis for Stevanato Group. With the share price at $17.08,...
Is Stevanato Group S.p.A. (STVN) A Good Stock To Buy Now?
Is STVN a good stock to buy? We came across a bullish thesis on Stevanato Group S.p.A. on Best Anchor Stocks’s Substack. In this article, we will summarize the bulls’ thesis on STVN. Stevanato Group S.p.A.’s share was trading at $18.10 as of June 9th. STVN’s trailing and forward P/E were 30.80 and 19.46 respectively according to […]